Tranilast - AltacorAlternative Names: ALT-401
Latest Information Update: 15 Jul 2016
At a glance
- Originator Altacor
- Class Anthranilic acids; Antiallergics; Antiasthmatics; Ischaemic heart disorder therapies; Small molecules
- Mechanism of Action Transforming growth factor beta inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Scars
Most Recent Events
- 15 Jul 2016 Chemical information added
- 14 Jul 2016 Early research is ongoing in United Kingdom